Multicenter Study to Evaluate Efficacy, Tolerability, Safety of Derinat

Summary

This multicenter prospective double blinded placebo-controlled randomized study is designed to to evaluate clinical efficacy, tolerability and safety of medical product Derinat®, solution for external and local use 0.25% in acute infections of respiratory system in children

Timeline

Start

2019-12-15

Primary completion

2022-05-31

Completion

2022-05-31

Drugs

Indications